Renal transplantation has become the preferred modality for renal replacement therapy
for most patients with end-stage renal disease. Registry analyses have shown an association
of transplantation with a significant improvement in mortality compared with patients
on dialysis awaiting a transplant. Over the past decade we have seen a tremendous
improvement in 1-year acute rejection rates. Acute rejection rates just a decade ago
were almost 50%, and now are 10% to 15%.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Seminars in NephrologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Article info
Identification
Copyright
© 2007 Elsevier Inc. Published by Elsevier Inc. All rights reserved.
